Table 2.

Short-chain cardiac acyl-carnitine levels for the different species assessed. Data are presented as mean ±SD. Two-way ANOVA. p-value displayed with the effect of streptozotocin (STZ), the effect of L-carnitine (Carn) and the interaction between the two effects.

	Control (CTR)		Streptozotocin (STZ)		STZ	Carn	Interaction
	Saline	L-Carnitine	Saline	L-Carnitine	p-Value	p-Value	p-Value
C2 (μmol/gww)	8.6 ± 4.9	11.3 ± 1.7	6.8 ± 3.8	10.1 ± 5.3	0.33	0.07	0.82
C3 (μmol/gww)	0.30 ± 0.11	0.73 ± 0.34	0.26 ± 0.14	1.09 ± 0.59	0.17	<0.0001	0.10
C4 (μmol/gww)	0.11 ± 0.03	0.39 ± 0.17	0.20 ± 0.09	0.36 ± 0.18	0.56	<0.0001	0.17
C5 (μmol/gww)	0.04 ± 0.02	0.12 ± 0.08	0.06 ± 0.04	0.24 ± 0.13	0.02	<0.0001	0.11
C5_1 (μmol/gww)	0.007 ± 0.003	0.010 ± 0.004	0.005 ± 0.003	0.007 ± 0.005	0.10	0.05	0.88
C6 (μmol/gww)	0.009 ± 0.004	0.055 ± 0.033	0.054 ± 0.034	0.089 ± 0.042	0.002	0.002	0.61
C8 (μmol/gww)	0.002 ± 0.001	0.010 ± 0.003	0.018 ± 0.012	0.024 ± 0.011	0.0002	0.04	0.85
C8_1 (μmol/gww)	7.0 ± 1.5 × 10−5	4.9 ± 2.5 × 10−5	8.2 ± 4.2 × 10−5	10.9 ± 3.2 × 10−5	0.02	0.82	0.11
C10 (μmol/gww)	0.002 ± 0.001	0.008 ± 0.002	0.015 ± 0.007	0.018 ± 0.011	<0.001	0.06	0.54
C10_1 (μmol/gww)	0.0002 ± 0.0001	0.0002 ± 0.0001	0.0003 ± 0.0001	0.0002± 0.0001	0.52	0.44	0.71